Pharmaceutical combinations comprising a mTOR inhibitor Raf kinase

Details for Australian Patent Application No. 2007251869 (hide)

Owner Novartis AG

Inventors Lane, Heidi

Agent Davies Collison Cave

Pub. Number AU-B-2007251869

PCT Pub. Number WO2007/131689

Priority 0609378.5 11.05.06 GB

Filing date 9 May 2007

Wipo publication date 22 November 2007

Acceptance publication date 21 July 2011

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/00 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

20 November 2008 PCT application entered the National Phase

  PCT publication WO2007/131689 Priority application(s): WO2007/131689

21 July 2011 Application Accepted

  Published as AU-B-2007251869

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007251879-Novel stress-related microrna molecules and uses thereof

2007251862-Ionization source and method for mass spectrometry